Nicaise Claude
SEC insider (Form 3/4/5 filer). CIK 0001644162. Director at Gain Therapeutics, Inc. (GANX) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BETHESDA, MD.
Companies Nicaise Claude has filed insider reports for
- Gain Therapeutics, Inc. (GANX): Director
- Sarepta Therapeutics, Inc. (SRPT): Director
- CASSAVA SCIENCES INC (SAVA): Director
Nicaise Claude
CIK: 0001644162
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 15, 2026GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
AwardDirect16.9K shares- - Jan 29, 2026SRPT
Sarepta Therapeutics, Inc.
ExerciseDirect10.5K shares at avg. $13.71$144K - Jan 29, 2026SRPT
Sarepta Therapeutics, Inc.
Tax PaymentDirect6.8K shares at avg. $21.23$144K - Jun 24, 2025GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15K shares- - May 23, 2025SAVA
CASSAVA SCIENCES INC
AwardDirectStock Option (Right to Buy)
26.5K shares- - Mar 12, 2025SRPT
Sarepta Therapeutics, Inc.
ExerciseDirect9.7K shares at avg. $25.18$245K - Mar 12, 2025SRPT
Sarepta Therapeutics, Inc.
SaleDirect2.5K shares at avg. $99.64$248K - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jun 4, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award | 16,875 | - | $0 | Direct |
| Jan 29, 2026 | SRPT Sarepta Therapeutics, Inc. | Exercise | 10,500 | $13.71 | $143,955 | Direct |
| Jan 29, 2026 | SRPT Sarepta Therapeutics, Inc. | Tax Payment | 6,780 | $21.23 | $143,939 | Direct |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 15,000 | - | - | Direct |
| May 23, 2025 |  SAVA CASSAVA SCIENCES INC | Award Stock Option (Right to Buy) | 26,500 | - | - | Direct |
| Mar 12, 2025 | SRPT Sarepta Therapeutics, Inc. | Exercise | 9,746 | $25.18 | $245,404 | Direct |
| Mar 12, 2025 | SRPT Sarepta Therapeutics, Inc. | Sale | 2,491 | $99.64 | $248,203 | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 2,383 | - | - | Direct |
1-9 of 9 transactions